<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="int-interactant" /><meta name="keywords" content="" /><title>Itraconazole: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="41001i302.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="41001i302.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=41001i302.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="41001.htm">Appendix 1 Interactions</a> &gt; <a href="53178.htm">List of drug interactions</a> &gt; <a href="41001i288.htm">Antifungals</a> &gt; <a href="41001i300.htm">Antifungals, Triazole</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="41001i301.htm" title="Previous: Fluconazole">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="41001i303.htm" title="Next: Antihistamines">Next page</a> ►</div></div></div></div><div id="p1"><div id="pB"><h1 id="_41001i302">Itraconazole</h1><div id="pC" class="jN"><p class="int-specific-drug-name"><b>Itraconazole</b>
          has the following interaction information:
        </p><table summary="Drug interactions" width="100%" border="0" cellspacing="2"><colgroup><col width="30%" class="cBT" /><col width="40%" class="cBS" /><col width="30%" class="cBU" /></colgroup><tbody><tr><td><a href="41001i86.htm" name="_86">Alfentanil</a></td><td> itraconazole possibly inhibits metabolism of alfentanil </td><td></td></tr><tr><td><a href="41001i1099.htm" name="_1099">Aliskiren</a></td><td class="cBV"><b> itraconazole increases plasma concentration of aliskiren—avoid concomitant use</b></td><td></td></tr><tr><td><a href="41001i406.htm" name="_406">Alprazolam</a></td><td> itraconazole increases plasma concentration of alprazolam </td><td></td></tr><tr><td><a href="41001i110.htm">Antacids</a></td><td>absorption of  itraconazole reduced by antacids </td><td>Antacids should preferably not be taken at the same time as other drugs since they may impair absorption</td></tr><tr><td><a href="41001i1217.htm" name="_1217">Apixaban</a></td><td>avoidance of  itraconazole advised by manufacturer of apixaban </td><td></td></tr><tr><td><a href="41001i1011.htm" name="_1011">Aripiprazole</a></td><td class="cBV"><b> itraconazole possibly inhibits metabolism of aripiprazole (reduce dose of aripiprazole)</b></td><td></td></tr><tr><td><a href="41001i601.htm">Atorvastatin</a></td><td class="cBV"><b>increased risk of myopathy when  itraconazole given with atorvastatin </b></td><td></td></tr><tr><td><a href="41001i943.htm" name="_943">Bosentan</a></td><td> itraconazole possibly increases plasma concentration of bosentan </td><td></td></tr><tr><td><a href="41001i496.htm" name="_496">Budesonide</a></td><td> itraconazole increases plasma concentration of <i>inhaled</i> budesonide </td><td></td></tr><tr><td><a href="41001i427.htm" name="_427">Buspirone</a></td><td> itraconazole increases plasma concentration of buspirone (reduce dose of buspirone)</td><td></td></tr><tr><td><a href="41001i993.htm" name="_993">Busulfan</a></td><td> itraconazole inhibits metabolism of busulfan (increased risk of toxicity)</td><td></td></tr><tr><td><a href="41001i1204.htm" name="_1204">Cabazitaxel</a></td><td class="cBV"><b>avoidance of  itraconazole advised by manufacturer of cabazitaxel </b></td><td></td></tr><tr><td><a href="41001i466.htm" name="_466">Calcium-channel Blockers</a></td><td>negative inotropic effect possibly increased when  itraconazole given with calcium-channel blockers </td><td>Dihydropyridine calcium-channel blockers include amlodipine, felodipine, isradipine, lacidipine, lercanidipine, nicardipine, nifedipine, and nimodipine</td></tr><tr><td><a href="41001i469.htm" name="_469">Calcium-channel Blockers (dihydropyridines)</a></td><td> itraconazole possibly inhibits metabolism of dihydropyridines (increased plasma concentration)</td><td></td></tr><tr><td><a href="41001i277.htm">Carbamazepine</a></td><td>plasma concentration of  itraconazole possibly reduced by carbamazepine </td><td></td></tr><tr><td><a href="41001i499.htm" name="_499">Ciclosporin</a></td><td class="cBV"><b> itraconazole inhibits metabolism of ciclosporin (increased plasma concentration)</b></td><td></td></tr><tr><td><a href="41001i168.htm">Clarithromycin</a></td><td>plasma concentration of  itraconazole increased by clarithromycin </td><td></td></tr><tr><td><a href="41001i865.htm" name="_865">Clopidogrel</a></td><td class="cBV"><b> itraconazole possibly reduces antiplatelet effect of clopidogrel </b></td><td></td></tr><tr><td><a href="41001i483.htm" name="_483">Colchicine</a></td><td class="cBV"><b> itraconazole possibly increases risk of colchicine toxicity—suspend or reduce dose of colchicine (avoid concomitant use in hepatic or renal impairment)</b></td><td></td></tr><tr><td><a href="41001i484.htm" name="_484">Corticosteroids</a></td><td> itraconazole possibly inhibits metabolism of corticosteroids </td><td>Interactions do not generally apply to corticosteroids used for topical action (including inhalation) unless specified</td></tr><tr><td><a href="41001i220.htm" name="_220">Coumarins</a></td><td class="cBV"><b> itraconazole enhances anticoagulant effect of coumarins </b></td><td>Change in patient’s clinical condition, particularly associated with liver disease, intercurrent illness, or drug administration, necessitates more frequent testing. Major changes in diet (especially involving salads and vegetables) and in alcohol consumption may also affect anticoagulant control</td></tr><tr><td><a href="41001i502.htm">Cyclophosphamide</a></td><td> itraconazole possibly increases side-effects of cyclophosphamide </td><td></td></tr><tr><td><a href="41001i1120.htm" name="_1120">Dabigatran Etexilate</a></td><td class="cBV"><b> itraconazole possibly increases plasma concentration of dabigatran etexilate—manufacturer of dabigatran etexilate advises avoid concomitant use</b></td><td></td></tr><tr><td><a href="41001i1076.htm" name="_1076">Darifenacin</a></td><td>avoidance of  itraconazole advised by manufacturer of darifenacin </td><td></td></tr><tr><td><a href="41001i480.htm" name="_480">Digoxin</a></td><td class="cBV"><b> itraconazole increases plasma concentration of digoxin </b></td><td></td></tr><tr><td><a href="41001i119.htm">Disopyramide</a></td><td class="cBV"><b>manufacturer of  itraconazole advises avoid concomitant use with disopyramide </b></td><td></td></tr><tr><td><a href="41001i1176.htm" name="_1176">Dronedarone</a></td><td class="cBV"><b>avoidance of  itraconazole advised by manufacturer of dronedarone </b></td><td></td></tr><tr><td><a href="41001i874.htm">Efavirenz</a></td><td>plasma concentration of  itraconazole reduced by efavirenz </td><td></td></tr><tr><td><a href="41001i963.htm" name="_963">Eletriptan</a></td><td class="cBV"><b> itraconazole increases plasma concentration of eletriptan (risk of toxicity)—avoid concomitant use</b></td><td></td></tr><tr><td><a href="41001i1025.htm" name="_1025">Eplerenone</a></td><td class="cBV"><b> itraconazole increases plasma concentration of eplerenone—avoid concomitant use</b></td><td></td></tr><tr><td><a href="41001i1169.htm" name="_1169">Everolimus</a></td><td class="cBV"><b> itraconazole possibly increases plasma concentration of everolimus—manufacturer of everolimus advises avoid concomitant use</b></td><td></td></tr><tr><td><a href="41001i471.htm" name="_471">Felodipine</a></td><td class="cBV"><b> itraconazole inhibits metabolism of felodipine (increased plasma concentration)</b></td><td></td></tr><tr><td><a href="41001i1119.htm" name="_1119">Fesoterodine</a></td><td>manufacturer of fesoterodine advises dose reduction when  itraconazole given with fesoterodine—consult fesoterodine product literature</td><td></td></tr><tr><td><a href="41001i1019.htm">Fosamprenavir</a></td><td>plasma concentration of both drugs may increase when  itraconazole given with fosamprenavir </td><td>Fosamprenavir is a prodrug of amprenavir</td></tr><tr><td><a href="41001i1170.htm" name="_1170">Gefitinib</a></td><td> itraconazole increases plasma concentration of gefitinib </td><td></td></tr><tr><td><a href="41001i387.htm" name="_387">Haloperidol</a></td><td> itraconazole possibly increases plasma concentration of haloperidol </td><td></td></tr><tr><td><a href="41001i743.htm">Histamine H<sub>2</sub>-antagonists</a></td><td>absorption of  itraconazole reduced by histamine H<sub>2</sub>-antagonists </td><td></td></tr><tr><td><a href="41001i398.htm" name="_398">Indinavir</a></td><td class="cBV"><b> itraconazole increases plasma concentration of indinavir (consider reducing dose of indinavir)</b></td><td></td></tr><tr><td><a href="41001i1050.htm" name="_1050">Ivabradine</a></td><td class="cBV"><b> itraconazole possibly increases plasma concentration of ivabradine—avoid concomitant use</b></td><td></td></tr><tr><td><a href="41001i1128.htm" name="_1128">Lapatinib</a></td><td class="cBV"><b>avoidance of  itraconazole advised by manufacturer of lapatinib </b></td><td></td></tr><tr><td><a href="41001i846.htm" name="_846">Lercanidipine</a></td><td>avoidance of  itraconazole advised by manufacturer of lercanidipine </td><td></td></tr><tr><td><a href="41001i492.htm" name="_492">Methylprednisolone</a></td><td> itraconazole possibly inhibits metabolism of methylprednisolone </td><td></td></tr><tr><td><a href="41001i1125.htm">Micafungin</a></td><td>plasma concentration of  itraconazole increased by micafungin (consider reducing dose of itraconazole)</td><td></td></tr><tr><td><a href="41001i421.htm">Midazolam</a></td><td class="cBV"><b> itraconazole increases plasma concentration of midazolam (risk of prolonged sedation)</b></td><td></td></tr><tr><td><a href="41001i841.htm">Mizolastine</a></td><td class="cBV"><b> itraconazole inhibits metabolism of mizolastine—avoid concomitant use</b></td><td></td></tr><tr><td><a href="41001i843.htm">Nevirapine</a></td><td>plasma concentration of  itraconazole possibly reduced by nevirapine—consider increasing dose of itraconazole</td><td></td></tr><tr><td><a href="41001i1118.htm" name="_1118">Nilotinib</a></td><td class="cBV"><b>avoidance of  itraconazole advised by manufacturer of nilotinib </b></td><td></td></tr><tr><td><a href="41001i1186.htm" name="_1186">Pazopanib</a></td><td class="cBV"><b>avoidance of  itraconazole advised by manufacturer of pazopanib </b></td><td></td></tr><tr><td><a href="41001i437.htm">Phenobarbital</a></td><td>plasma concentration of  itraconazole possibly reduced by phenobarbital </td><td></td></tr><tr><td><a href="41001i284.htm">Phenytoin</a></td><td class="cBV"><b>plasma concentration of  itraconazole reduced by phenytoin—avoid concomitant use</b></td><td></td></tr><tr><td><a href="41001i751.htm">Proton Pump Inhibitors</a></td><td>absorption of  itraconazole reduced by proton pump inhibitors </td><td></td></tr><tr><td><a href="41001i1147.htm" name="_1147">Ranolazine</a></td><td class="cBV"><b> itraconazole possibly increases plasma concentration of ranolazine—manufacturer of ranolazine advises avoid concomitant use</b></td><td></td></tr><tr><td><a href="41001i855.htm" name="_855">Repaglinide</a></td><td> itraconazole possibly enhances hypoglycaemic effect of repaglinide </td><td></td></tr><tr><td><a href="41001i200.htm">Rifabutin</a></td><td class="cBV"><b>plasma concentration of  itraconazole reduced by rifabutin—manufacturer of itraconazole advises avoid concomitant use</b></td><td></td></tr><tr><td><a href="41001i201.htm">Rifampicin</a></td><td class="cBV"><b>plasma concentration of  itraconazole reduced by rifampicin—manufacturer of itraconazole advises avoid concomitant use</b></td><td></td></tr><tr><td><a href="41001i400.htm" name="_400">Ritonavir</a></td><td class="cBV"><b>combination of  itraconazole with ritonavir may increase plasma concentration of either drug (or both)</b></td><td></td></tr><tr><td><a href="41001i1136.htm" name="_1136">Rivaroxaban</a></td><td>avoidance of  itraconazole advised by manufacturer of rivaroxaban </td><td></td></tr><tr><td><a href="41001i858.htm" name="_858">Sildenafil</a></td><td> itraconazole increases plasma concentration of sildenafil—reduce initial dose of sildenafil</td><td></td></tr><tr><td><a href="41001i605.htm">Simvastatin</a></td><td class="cBV"><b>increased risk of myopathy when  itraconazole given with simvastatin (avoid concomitant use)</b></td><td></td></tr><tr><td><a href="41001i921.htm" name="_921">Sirolimus</a></td><td class="cBV"><b> itraconazole increases plasma concentration of sirolimus—avoid concomitant use</b></td><td></td></tr><tr><td><a href="41001i1020.htm" name="_1020">Solifenacin</a></td><td> itraconazole increases plasma concentration of solifenacin </td><td></td></tr><tr><td><a href="41001i730.htm" name="_730">Tacrolimus</a></td><td class="cBV"><b> itraconazole increases plasma concentration of tacrolimus (consider reducing dose of tacrolimus)</b></td><td>Interactions do not generally apply to tacrolimus used topically; risk of facial flushing and skin irritation with alcohol consumption (<a title="monograph: TACROLIMUS" href="119635.htm#_119635">see section 13.5.3</a>) does not apply to tacrolimus taken systemically</td></tr><tr><td><a href="41001i945.htm" name="_945">Tadalafil</a></td><td> itraconazole possibly increases plasma concentration of tadalafil </td><td></td></tr><tr><td><a href="41001i1216.htm">Telaprevir</a></td><td>plasma concentration of  itraconazole possibly increased by telaprevir </td><td></td></tr><tr><td><a href="41001i850.htm" name="_850">Tolterodine</a></td><td>avoidance of  itraconazole advised by manufacturer of tolterodine </td><td></td></tr><tr><td><a href="41001i967.htm" name="_967">Vardenafil</a></td><td class="cBV"><b> itraconazole possibly increases plasma concentration of vardenafil—avoid concomitant use</b></td><td></td></tr><tr><td><a href="41001i815.htm" name="_815">Vincristine</a></td><td class="cBV"><b> itraconazole possibly inhibits metabolism of vincristine (increased risk of neurotoxicity)</b></td><td></td></tr><tr><td><a href="41001i1181.htm" name="_1181">Vinflunine</a></td><td class="cBV"><b> itraconazole possibly increases plasma concentration of vinflunine—manufacturer of vinflunine advises avoid concomitant use</b></td><td></td></tr><tr><td><a href="41001i1085.htm" name="_1085">Vinorelbine</a></td><td class="cBV"><b> itraconazole possibly inhibits metabolism of vinorelbine (increased risk of neurotoxicity)</b></td><td></td></tr></tbody></table><p>Itraconazole belongs to <b>Antifungals, Triazole</b>
          and will have the following interactions:
        </p><table summary="Drug interactions" width="100%" border="0" cellspacing="2"><colgroup><col width="30%" class="cBT" /><col width="40%" class="cBS" /><col width="30%" class="cBU" /></colgroup><tbody>










<tr><td><a href="41001i290.htm">Amphotericin</a></td><td> triazoles possibly antagonise effects of amphotericin </td><td>Close monitoring required with concomitant administration of nephrotoxic drugs or cytotoxics</td></tr><tr><td><a href="41001i937.htm">Artemether with Lumefantrine</a></td><td class="cBV"><b>avoidance of  triazoles advised by manufacturer of artemether/lumefantrine </b></td><td></td></tr><tr><td><a href="41001i601.htm">Atorvastatin</a></td><td>possible increased risk of myopathy when  triazoles given with atorvastatin </td><td></td></tr><tr><td><a href="41001i563.htm">Ergotamine and Methysergide</a></td><td class="cBV"><b>increased risk of ergotism when  triazoles given with ergotamine and methysergide—avoid concomitant use</b></td><td></td></tr><tr><td><a href="41001i95.htm">Fentanyl</a></td><td class="cBV"><b> triazoles possibly increase plasma concentration of fentanyl </b></td><td></td></tr><tr><td><a href="41001i369.htm">Pimozide</a></td><td class="cBV"><b>increased risk of ventricular arrhythmias when  triazoles given with pimozide—avoid concomitant use</b></td><td></td></tr><tr><td><a href="41001i824.htm">Quetiapine</a></td><td class="cBV"><b> triazoles possibly increase plasma concentration of quetiapine—manufacturer of quetiapine advises avoid concomitant use</b></td><td></td></tr><tr><td><a href="41001i231.htm">Reboxetine</a></td><td class="cBV"><b>avoidance of  triazoles advised by manufacturer of reboxetine </b></td><td></td></tr><tr><td><a href="41001i200.htm">Rifabutin</a></td><td class="cBV"><b> triazoles possibly increase plasma concentration of rifabutin (increased risk of uveitis—reduce rifabutin dose)</b></td><td></td></tr><tr><td><a href="41001i791.htm">Saquinavir</a></td><td> triazoles possibly increase plasma concentration of saquinavir </td><td></td></tr></tbody></table><p>Itraconazole belongs to <b>Antifungals</b>
          but <b>Antifungals</b>
          has no interactions information.
        </p></div><?highlighter on?><?highlighter off?><div id="pE">◄ <a accesskey="[" href="41001i301.htm">Previous: Fluconazole</a> | <a class="top" href="41001i302.htm#">Top</a> | <a accesskey="]" href="41001i303.htm">Next: Antihistamines</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>